Mwandishi:
Mhariri:
Imeboershwa:
ULY CLINIC
ULY CLINIC
17 Februari 2026, 14:31:27
Oculo-cutaneous Albinism
Oculocutaneous albinism (OCA) is a congenital inherited disorder characterized by a complete or partial absence of melanin pigment in the skin, hair, and eyes due to defective melanin synthesis.
It is caused by mutations affecting tyrosine → melanin conversion in melanocytes. The condition is lifelong and present from birth.
Individuals with OCA have:
Markedly increased risk of skin cancers
Significant visual impairment
Inheritance pattern: Autosomal recessive
Pathophysiology (Brief)
Melanin protects against ultraviolet radiation and supports normal retinal development. Deficiency leads to:
Skin effects:
Sun sensitivity
DNA damage → cancers
Eye effects:
Foveal hypoplasia
Misrouting of optic nerves
Reduced visual acuity
Signs & Symptoms
Ocular features:
Strabismus (crossed eyes)
Photophobia (light sensitivity)
Nystagmus (rapid involuntary eye movement)
Reduced vision or blindness
Astigmatism
Skin & hair features:
Very light or white hair
Pale skin
Easy sunburn
Freckles or sun spots at early age
Diagnostic Criteria
Diagnosis is clinical when typical pigmentation plus ocular abnormalities exist:
Strabismus
Photophobia
Nystagmus
Visual impairment or blindness
Astigmatism
Investigations
Usually clinical diagnosis, but investigations help confirm and monitor complications:
Ophthalmic assessment
Visual acuity testing
Refraction test (for astigmatism)
Fundoscopy → foveal hypoplasia
Optical coherence tomography (OCT)
Dermatological assessment
Skin examination for premalignant lesions
Biopsy if suspicious lesion present
Genetic tests (if available)
Mutation confirmation
Family counseling
Management
Non-Pharmacological Treatment
Genetic counseling (very important to prevent recurrence in family)
Protective clothing:
Long-sleeved shirts
Trousers or long skirts
Wide-brimmed hats
Sun-protective glasses with UVB filters
Avoid outdoor work under strong sunlight
Advice on indoor income-generating activities
Regular dermatology screening for early cancer detection
Regular ophthalmology follow-up
Pharmacological Treatment
Sunscreen SPF ≥30
Apply twice daily (8:00 AM and 12:00 PM)
Reapply after sweating or washing
Referral
Refer urgently to higher center if:
Suspicious skin lesion
Non-healing ulcer
Rapidly growing mass
Pigmented or bleeding lesion
(Suspected skin cancer)
Complications
Squamous cell carcinoma (commonest)
Basal cell carcinoma
Actinic keratosis
Severe visual disability
Social stigma and psychological distress
Prevention
Primary prevention is not possible (genetic condition), but complications can be prevented:
Lifelong sun protection
Early treatment of precancerous lesions
Routine skin screening every 6–12 months
Vision correction early in childhood
Genetic counseling before marriage/pregnancy
References
Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 6th ed. Dodoma: MoH; 2023.
World Health Organization. Guidelines for the management of common skin diseases. Geneva: WHO; 2014.
Kromberg JGR, Manga P. Albinism in Africa: genetics and public health implications. J Dermatol. 2018;45(4):407-414.
Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. Elsevier; 2018.
National Institute for Health and Care Excellence (NICE). Skin cancer prevention guidance. London: NICE; 2020.
Imeandikwa;
3 Novemba 2020, 12:46:48
